UB-421: Clinical Trials

1 trial of UB-421, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Withdrawn 1

Follow UB-421: new trials by email Literature Review of UB-421 trials Research Report on UB-421

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults
UB-421, current standard HAART treatment - HIV-1 Infection
Phase 3WithdrawnUnited BioPharma2025-04-012023-04-25

Sponsors

United BioPharma (1)

Countries

China (1)